Sirolimus for patients with progressive epithelioid hemangioendothelioma.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 33107994.
- Also identified by DOI 10.1002/cncr.33246 and PMC identifier 7894141.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Epithelioid hemangioendothelioma is an ultrarare soft tissue sarcoma with limited literature to guide treatment. The results from a robust retrospective cohort study support the use of sirolimus for patients who have multifocal epithelioid hemangioendothelioma without serosal effusion.
Medical subject headings
- Hemangioendothelioma, Epithelioid
- Sarcoma